-
BRKR Buys VARI’s Assets; Deal To Be Accretive In 2010-11
Wednesday, March 10, 2010 - 12:57pm | 209Analysts at UBS reiterate their "neutral" rating on Bruker Corp (NASDAQ: BRKR). The target price for BRKR has been raised from $14 to $15. Bruker has said that it will be purchasing certain assets from Varian Inc (NASDAQ: VARI) that requires divesture when Agilent (NYSE: A) acquires VARI. “...
-
Jim Rogers Says Watch It All
Tuesday, March 9, 2010 - 9:28am | 819The crew over at Wall Street Cheat Sheet posted a quick interview they conducted with Jim Rogers. There was one line in there that really resonated with me and was something new (to me anyway) in terms of his usual message. More like an addition to his usual message. Interviewer Damien Hoffman...
-
Stocks That Created New 52-Week Highs (BKCC, CSCO, BRKR, CKEC, CMRG)
Monday, March 8, 2010 - 3:18pm | 244BlackRock Kelso Capital Corporation (NASDAQ: BKCC) shares added 1.01% to create a new 52-week high of $9.99. BKCC’s trailing twelve-month operating margins stand at 81.24%. Read more about this company here. Amylin Pharmaceuticals Inc (NASDAQ: CSCO) shares climbed to $32.16, creating a new 52-week...
-
Benzinga’s Top Pre-Market Losers (SSTI, UTSI, MDVN, CIEN, ARMH)
Monday, March 8, 2010 - 9:35am | 289Silicon Storage Technology, Inc. (NASDAQ: SSTI) decreased 6.15% to $3.05 in the pre-market session. Silicon Storage Technology announced today that it has entered into an amendment to its previously announced merger agreement with Microchip Technology Incorporated (Nasdaq: MCHP). Under the terms...
-
Goldman Sachs (GS) VIP List of Top Hedge Fund Holdings
Friday, March 5, 2010 - 1:19pm | 1198Today is going to be Goldman Sachs (GS) day at FMMF - from their nearly perfect forecasting of monthly labor data (magically adjusting their figures 24 hours before it is released each month to "hit it on the nail"), to their new foray into buying warehouses so they can corner obtain more...
-
The Impact of Recent Merger Activity on Options Trading
Thursday, March 4, 2010 - 5:23pm | 1941Through the first two months of 2010, it appears the merger and acquisition party of the late 90s and early 2000 could be raring up once again. As Warren Buffett pointed out in his annual letter to shareholders, bankers don’t get paid for suggesting that companies not do deals, they get paid to...
-
Company News for March 4, 2010 - Corporate Summary
Thursday, March 4, 2010 - 10:08am | 313• Pfizer (NYSE:PFE) led DJIA stocks on the downside yesterday after Medivation (NASDAQ:MDVN) said its experimental treatment for Alzheimer's, Dimebon, developed with Pfizer, failed to show desired results in late-stage trials • Anheuser-Busch InBev (NYSE:BUD) posted adjusted earnings of 55 cents a...
-
Stock Market News for March 4, 2010 - Market News
Thursday, March 4, 2010 - 10:05am | 439Stocks gave up early gains and closed the day almost unchanged as President Obama’s call for a healthcare overhaul legislation “in the next few weeks" weakened stocks from the sector and offset enthusiasm that followed a better-than-expected jobs report and an upbeat report on service industries....
-
Bullish on Pozen - Analyst Blog
Wednesday, March 3, 2010 - 4:03pm | 1281Pozen (POZN) remains one of our top picks in the small-to-mid cap biotechnology industry. We view the company as financially sound, exiting 2009 with over $46 million in cash on hand and another potential $20 million coming in April 2010 from AstraZeneca (AZN) for the U.S. approval of Vimovo. The...
-
Medivation Inc. (MDVN) Shows All Signs Of Moving Into Deep Correction
Wednesday, March 3, 2010 - 2:55pm | 151Pfizer Co. (NYSE: PFE) and partner Medivation Inc. (NASDAQ: MDVN) said Wednesday that the drug, Dimebon, failed to meet its primary and secondary goals of improving thinking ability and overall daily function over six months in patients with mild to moderate Alzheimer's disease. The failure to...
-
Benzinga’s Top Downgrades (LCAV, MDVN, VISN, HELE, LCC)
Wednesday, March 3, 2010 - 2:27pm | 262LCA-Vision Inc (NASDAQ: LCAV) was downgraded by Maxim Group from “hold” to “sell.” LCAV’s shares slipped 9.87% to $7.65 by 11:59 a.m. LCAV’s trailing-twelve-month return on equity stands at -49.61%. Read more about this company here. Roth Capital downgraded Medivation Inc (NASDAQ: MDVN) from “buy...
-
MDVN’s Dimebon Fails To Meet Endpoints In AD Study
Wednesday, March 3, 2010 - 1:58pm | 149Analysts at JP Morgan reiterate their “overweight” rating on Medivation (NASDAQ: MDVN). Medivation has announced that “the CONNECTION study of dimebon in patients with mild-to-moderate Alzheimer’s disease (AD) failed to meet its coprimary and secondary endpoints,” the research note says. “…we...
-
William Blair Maintains Nektar Therapeutics (NKTR) Outperform Rating
Wednesday, March 3, 2010 - 12:20pm | 102William Blair & Company analysts John Sonnier, Timothy Lugo and Karen Jay maintained their Outperform rating for shares of Nektar Therapeutics (Nasdaq: NKTR). The analysts mentioned the many products in the company's pipeline and its strong balance sheet as reasons for their positive rating for...
-
NKTR An Attractive Holding For The Long Term
Wednesday, March 3, 2010 - 10:44am | 66Analysts at JP Morgan maintain their "overweight" rating on Nektar (NASDAQ: NKTR). The target price for NKTR has been raised from $13 to $16. NKTR had posted healthy Q4 results. According to JP Morgan, Nektar continues to be an attractive long-term holding. NKTR’s shares closed at $12.53 yesterday...
-
Tuesday's Hot Stocks: One Fahionable Option Trade
Wednesday, March 3, 2010 - 10:27am | 2788With the major indices trading slightly higher Tuesday, there were 28 stocks which broke higher on BIG volume. If this is your first time reading one of my breakout reports you'll want to read the section below, however if you are familiar with my daily breakout report you should skip ahead to...